Metformin promotes innate immunity through a conserved PMK-1/p38 MAPK pathway
Metformin, as the first-line oral drug for type 2 diabetes, has proven benefits against aging, cancer and cardiovascular diseases. But the influence of metformin to the immune response and its molecular mechanisms remain obscure. Metformin increases resistance to not only the Gram-negative pathogens...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Taylor & Francis Group
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ce01c8a67b434c479938e84cc840fcfc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|